Haiming Feng

Lanzhou University Second Hospital

Papers

1

Total Citations

4

H-Index

1

About

Dr. Haiming Feng is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for esophageal cancer treatment, particularly through comparative analyses of robotic and thoracoscopic approaches. His most cited work, a 2023 study on short-term outcomes of robot-assisted versus thoracoscopic-assisted Mckeown esophagectomy, addresses a critical gap in surgical oncology by systematically evaluating the relative benefits of these two common procedures. Through a rigorous single-centre retrospective analysis, Dr. Feng provides evidence-based insights that help surgeons optimize patient outcomes, with this landmark paper accumulating 4 citations in a short period—a strong indicator of its growing influence in the field. His contributions are particularly notable for their clinical relevance, offering clear, data-driven guidance on surgical decision-making in esophageal cancer management. Dr. Feng’s work stands out for its methodological precision and direct impact on operative practice, making him a respected voice in the evolution of thoracic surgical techniques. His research continues to shape how surgeons approach esophagectomy, balancing technological innovation with patient safety and recovery.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Short‐term outcomes of robot‐assisted versus thoracoscopic‐assisted Mckeown esophagectomy
4 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Lanzhou University Second Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago